| Characteristic | No. of patients | Percentage (%) |
---|---|---|---|
Age (years old) | Median | 74 | |
 | 70–74 75–79 ≥80 | 44 20 9 | 60.3 27.4 12.3 |
Histology | Squamous cell carcinoma | 68 | 93.2 |
 | Adenocarcinoma | 4 | 5.5 |
 | Small cell carcinoma | 1 | 1.4 |
Stage | IB | 9 | 12.3 |
IIA | 12 | 16.4 | |
IIB | 32 | 43.8 | |
IIIA | 6 | 8.2 | |
IIIB | 9 | 12.3 | |
IVA | 5 | 6.8 | |
LNM | Pelvic LNM | 7 | 9.6 |
Para-aortic LNM | 2 | 2.7 | |
 | Pelvic and para-aortic LNM | 2 | 2.7 |
External beam radiation therapy technique | 3D–CRT | 21 | 28.8 |
IMRT | 52 | 71.2 | |
Dose of intracavitary brachytherapy | <30 Gy | 19 | 26.0 |
30-36 Gy | 50 | 68.5 | |
>36 Gy | 4 | 5.5 | |
Completion of radiotherapy | Yes | 70 | 95.9 |
 | No | 3 | 4.1 |
Duration of radiotherapy | ≤8 weeks | 58 | 79.5 |
>8Â weeks | 15 | 20.5 | |
Concurrent chemotherapy | No | 49 | 67.1 |
1-3Â cycles | 13 | 17.8 | |
≥4 cycles | 11 | 15.1 |